Atisha Manhas is an Oncology physician affiliated with Methodist Dallas Medical Center. OpenAlex indexes 5 publications with 4,144 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1441 N Beckley Ave
Suite 101
Dallas, TX 752031201
Telephone
214-943-9911Registry record last updated 5 Jul 2017.
Industry payments
44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202512 payments
- Janssen Biotech, Inc.Program year20257 payments
- Tempus AI, IncProgram year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
70.8%Other antiemetics56.8%Fosaprepitant100%Part B, office-administered≥12 patientsSerotonin-3 Receptor Antagonist12.3%Granisetron hydrochloride56%Palonosetron hcl36%Ondansetron Odt8%Part D + Part B≥28 patients+ 4 more classes in this area
Cancer & immunology
11.1%Aromatase Inhibitor8.2%Anastrozole86%Exemestane10%Letrozole4%Part D<11 patientsKinase inhibitor1.5%Ibrance27%Kisqali20%Imbruvica13%Inlyta13%Sprycel13%Tagrisso13%Part D<11 patients+ 4 more classes in this area
Sensory organs
9.4%Corticosteroid9.4%Dexamethasone sodium phosphate95%Dexamethasone5%Part D + Part B<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Detection of <i>Clostridium difficile</i> Toxin: Comparison of Enzyme Immunoassay Results with Results Obtained by Cytotoxicity Assay
Journal of Clinical Microbiology
2007 - Subcutaneous Sumatriptan in the Acute Treatment of Migraine in Patients Using Dihydroergotamine as Prophylaxis
Headache The Journal of Head and Face Pain
1993
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Tarnasky, MD
Methodist Dallas Medical Center
Prashant Kedia, MD
Methodist Dallas Medical Center
Mangesh Pagadala, MD
Methodist Dallas Medical Center
Jeffrey Sandate, MD
Methodist Dallas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”